Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

Nom du journal : PlosOne

Année : 2018

Volume : 13

Page de départ : e0204973

Auteurs: Berton-Rigaud D, Leary A, Lesoin A, Cottu PH, Sablin MP, Campone M, Italiano A, Floquet A, Diéras V, Bosq J, Bonneterre J, Varga A, Rezai K, Lokiec FM, Lhomme C, Bexon AS, Gilles EM, Proniuk S, Jackson DM, Zukiwski A,